Regen BioPharma Company Executives
| RGBP Stock | USD 0.06 0 8.17% |
Discussion of Regen BioPharma's management performance can provide insight into the enterprise performance.
| David Koos Chairman Chairman of the Board, CEO, CFO, Treasurer, Secretary |
Regen |
Regen BioPharma Management Team Effectiveness
The company has return on total asset (ROA) of (0.7581) % which means that it has lost $0.7581 on every $100 spent on assets. This is way below average. Regen BioPharma's management efficiency ratios could be used to measure how well Regen BioPharma manages its routine affairs as well as how well it operates its assets and liabilities.Regen BioPharma Workforce Comparison
Regen BioPharma is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 494. Regen BioPharma adds roughly 1.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 6.09 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (2.96) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.96. Regen BioPharma Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Regen BioPharma Price Series Summation is a cross summation of Regen BioPharma price series and its benchmark/peer.
Regen BioPharma Stakeholder
| David Koos | Chairman of the Board, CEO, CFO, Treasurer, Secretary | Profile |
About Regen BioPharma Management Performance
The success or failure of an entity such as Regen BioPharma often depends on how effective the management is. Regen BioPharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Regen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Regen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California. Regen Biopharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Regen BioPharma Workforce Analysis
Traditionally, organizations such as Regen BioPharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Regen BioPharma within its industry.Regen BioPharma Manpower Efficiency
Return on Regen BioPharma Manpower
| Revenue Per Employee | 235.5K | |
| Net Income Per Employee | 2.4M |
Additional Tools for Regen Pink Sheet Analysis
When running Regen BioPharma's price analysis, check to measure Regen BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regen BioPharma is operating at the current time. Most of Regen BioPharma's value examination focuses on studying past and present price action to predict the probability of Regen BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regen BioPharma's price. Additionally, you may evaluate how the addition of Regen BioPharma to your portfolios can decrease your overall portfolio volatility.